Panbela set to join russell microcap® index

Minneapolis, june 08, 2021 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, is set to join the russell microcap® index at the conclusion of the 2021 russell indexes annual reconstitution effective after the us market opens on june 28, according to a preliminary list of additions posted june 4.
PBLA Ratings Summary
PBLA Quant Ranking